SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

03 Aug 2022 Evaluate

Sun Pharmaceutical Industries has informed that it enclosed its Press Release titled ‘Sun Pharma Chairman, Israel Makov to retire on completion of term’. The Press Release shall be released after sending this letter.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1667.50 -0.50 (-0.03%)
21-Apr-2026 11:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1667.50
Dr. Reddys Lab 1221.70
Cipla 1231.85
Zydus Lifesciences 929.50
Lupin 2322.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×